home / stock / oprx / oprx news

OPRX News and Press, OptimizeRx Corporation From 02/22/22

Stock Information
Company Name: OptimizeRx Corporation
Stock Symbol: OPRX
Market: NASDAQ
Website: optimizerx.com
Menu
OPRX OPRX Quote OPRX Short OPRX News OPRX Articles OPRX Message Board
Get OPRX Alerts

News, Short Squeeze, Breakout and More Instantly...
OPRX - Top 10 Pharma Deploys OptimizeRx's Digital Access Solution to Streamline Patient Therapy Initiation Challenges

ROCHESTER, Mich., Feb. 22, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the launch of a large-scale therapy initiation pr...
OPRX - OptimizeRx announces preliminary Q4 results

OptimizeRx (NASDAQ:OPRX) announces preliminary Q4 revenue of $20.3M, resulting in a Y/Y growth of 42%. Improved gross margins and continued cost management are expected to result in a GAAP net income of $0.6M for Q4 as well as a record quarterly adjusted EBITDA of $4M. 2022 Guidance: FY ...

OPRX - OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance

ROCHESTER, Mich., Feb. 15, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced preliminary unaudited financial and operatio...

OPRX - OptimizeRx Sets Fourth Quarter and Full Year 2021 Conference Call for Thursday, February 24 at 4:30 p.m. ET

ROCHESTER, Mich., Feb. 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Thursday, February 24, 2022, at&...
OPRX - OptimizeRx CEO, William Febbo, to Speak at the Bank of America Annual HCIT and Digital Health Conference

ROCHESTER, Mich., Feb. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX),  a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that Will Febbo, OptimizeRx’s CEO, w...

OPRX - OptimizeRx's Mike Rousselle Named to MM+M's 40 Under 40 List of the Medical Marketing Industry's Brightest Young Stars

ROCHESTER, Mich., Feb. 01, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced its vice president of data product, Mike Rou...

OPRX - OptimizeRx to Participate in Upcoming February Investor Conferences

ROCHESTER, Mich., Jan. 31, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced today that members of its leadership team will atte...
OPRX - 3 Under-the-Radar COVID Stocks

COVID-19 has created a lot of volatility in the stock market. The whole market crashed in 2020, but many stocks quickly recovered. Indeed, there have been some high-flying pharmaceutical stocks that have skyrocketed as the biotech industry has fought back against the virus. And there are al...

OPRX - OptimizeRx's AI-Driven Therapy Initiation and Persistence Platform Wins 2022 BIG Innovation Award

ROCHESTER, Mich., Jan. 18, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced it has been named a winner in the 2022 BIG I...

OPRX - OptimizeRx to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022

Panel to take place January 6, 2022 at 8:30am ET ROCHESTER, Mich., Jan. 03, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today an...
Previous 10 Next 10